Radiation therapy for recurrent esophageal cancer after surgery: Clinical results and prognostic factors

Japanese Journal of Clinical Oncology

Volumn 37, Issue 12, 2007, Pages 918-923

  Shioyama, Yoshiyuki ^a   Nakamura, Katsumasa ^a   Ohga, Saiji ^a   Nomoto, Satoshi ^a   Sasaki, Tomonari ^a   Yamaguchi, Toshihiro ^a   Toba, Takashi ^a   Yoshitake, Tadamasa ^a   Terashima, Hiromi ^b   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Radiation therapy; Recurrence after surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; NEDAPLATIN; TEGAFUR;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION PNEUMONIA; RADIATION RESPONSE; RECURRENT CANCER; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 38749126258     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym138     Document Type: Article

References (17)

1. Ando N, Oazawa S, Kitagawa Y, et al. Improvement in the results of treatment of advanced squamous esophageal carcinoma over fifteen consecutive years. Ann Surg 2000;232:225-32.
2. Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275-81.
3. Collard JM, Otte JB, Reynaert MS, et al. Extensive lymph node clearance for cancer of the esophagus or cardia: Merits and limits in reference to 5-year absolute survival. Hepatogastroenterology 1995;42:619-27.
4. Tam PC, Siu KF, Cheung HC, Ma L, Wong J. Local recurrence after subtotal esophagectomy for squamous cell carcinoma. Ann Surg 1987;205:189-94.
5. Raoul JL, Le Prise E, Meunier B, et al. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995;37:174-6.
6. Nemoto K, Ariga H, Kakuto Y, et al. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol 2001;61:165-8.
7. Yamashita H, Nagasawa K, Tago M, Nakamura N, Shiraishi K, Ohtomo K. Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer. Dis Esophagus 2005;18:215-20.
8. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 5th ed. New York: Wiley 1997.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Nishimura Y, Koike R, Nakamatsu K, et al. Concurrent chemoradiotherapy with protracted intusion of 5-FU and cisplatin for postoperative or residual esophageal cancer. Jpn J Clin Oncol 2003;33:341-5.
11. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20-49-36.
12. Herskovic A, Martz K, al-Sarraf M, et al, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-98.
13. Nemoto K, Matsushita H, Ogawa Y, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol 2003;26:46-9.
14. Sasaki Y, Amano T, Morita M, et al. Phase I study and pharmacological analysis of cis-diammine (glycolato) platinum (254-S: NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 1991;51:1472-7.
15. Jingu K, Nemoto K, Matsushita H, et al. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer 2006;6:1-9.
16. Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo, et al. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 2004; 15:955-9.
17. Airoldi M, Cartesina G, Giordano C, Pedani F, Bumma C, Gabuiele P. Docetaxel and vinorelbine: An effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol 2003;20:19-24.